Diadema Partners »

Nurix Therapeutics shares owned by Diadema Partners

Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Nurix Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nurix Therapeutics held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nurix Therapeutics by Diadema Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.9M 122k 24.26

More positions owned by Diadema Partners

Abivax Sa Sponsored Ads Call Option (ABVX)
Viking Therapeutics (VKTX)
Bristol Myers Squibb Put Option (BMY)
Amgen Call Option (AMGN)
United Therapeutics Corporation (UTHR)
Revolution Medicines (RVMD)
Uniqure Nv SHS Put Option (QURE)
Novartis Sponsored Adr Call Option (NVS)
Kodiak Sciences Call Option (KOD)
Capricor Therapeutics Com New Put Option (CAPR)
Cogent Biosciences (COGT)
Bridgebio Pharma Note 1.750% 3/0 (Principal)
Corcept Therapeutics Incorporated Call Option (CORT)
BioMarin Pharmaceutical (BMRN)
Kymera Therapeutics Call Option (KYMR)

View all positions for Diadema Partners

Top funds holding Nurix Therapeutics

BlackRock
Vestal Point Capital
Deep Track Capital
Rubric Capital Management
FMR
State Street Corporation
Morgan Stanley
Baker Bros. Advisors
Vanguard Capital Management
Perceptive Advisors
Redmile Group
T. Rowe Price Associates
General Atlantic
Geode Capital Management
Pictet Asset Management Holding SA

View all funds holding Nurix Therapeutics